FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and can be used to treat or prevent intrahepatic cholestasis of pregnant women in a subject. For this, the use of a composition comprising probiotic bacterial strains is used, one of which has the activity of deconjugating bile acid, the second has the activity of 7-epimerization or has the activity of 7α-hydroxysteroid dehydrogenase (HSDH) and the third has the activity of 7β-HSDH. Also proposed are a medication and medication use.
EFFECT: group of inventions provides treatment or prevention of intrahepatic cholestasis in patients who need it.
21 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING RESPONSE OF A PATIENT DIAGNOSED WITH SKIN MELANOMA TO ANTI-PD1-THERAPY | 2020 |
|
RU2771080C2 |
PROBIOTIC BACTERIAL STRAIN FOR OBTAINING NUTRIENT COMPOSITION IMPROVING SLEEP NATURE | 2009 |
|
RU2642301C9 |
NOURISHING COMPOSITION, INCLUDING PROBIOTICS AND IMPROVING SLEEP PATTERN | 2009 |
|
RU2517616C2 |
PROBIOTIC COMPOSITION INTENDED FOR BABIES WITH LOW BODY WEIGHT AT BIRTH | 2009 |
|
RU2509478C2 |
DIARRHOEA RISK REDUCTION | 2008 |
|
RU2491080C2 |
PROBIOTICS USE FOR PSORIASIS TREATMENT AND/OR PREVENTION | 2017 |
|
RU2767967C2 |
PROBIOTICS FOR REDUCING RISK OF OBESITY | 2008 |
|
RU2464994C2 |
PROBIOTIC BACTERIAL STRAIN (VERSIONS) AND SYMBIOTIC COMPOSITION CONTAINING STRAINS FOR CHILD NUTRITION | 2012 |
|
RU2624043C2 |
COMPOSITIONS CONTAINING PROBIOTIC AND PREBIOTIC INGREDIENTS AND INORGANIC SALTS WITH LACTOFERRIN | 2010 |
|
RU2536939C2 |
MICROORGANISM COMPOSITION (VARIANTS) | 2002 |
|
RU2291899C2 |
Authors
Dates
2021-02-18—Published
2016-12-14—Filed